Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45) - Image 1

£137.71

Springer Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

Name: Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
Brand: Springer
Price: 137.71 GBP
Availability: InStock

Oncology

It has never been this cheap. We have no record of a lower price.

£138 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 28 days • 28 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 28 days • 1 price levels

Days at Price

Price Analysis

Most common price: £138 (28 days, 100.0%)

Price range: £138 - £138

Price levels: 1 different prices over 28 days

Description

Relapse of leukemia following successful remission-induction therapy remains a major obstacle in the treatment of patients with acute leukemia. Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation. ' It is likely that the great majority of these recurrences originate from residual leukemic cells that survive initial remission-induction chemotherapy. Today, several research groups throughout the world place emphasis on studies concerned with the detection and treatment of 'minimal residual disease' (MRD). These investigations are conducted with the common objective to tackle the remaining cells. 'Minimal Residual Disease in Acute Leukemia: 1986' summarizes the fast advancements in this area. Several disciplines are concerned with the analysis of leukemic cells. The perspectives of cytogenetic and molecular genetic approaches for applica tion in the detection of MRD are reviewed. In this respect, modern cyto genetics provide highly specific tumor markers. The resolution of cyto genetic methods can be particularly improved when combined with other techniques which select relevant subpopulations of cells. Characterization of oncogenes and gene rearrangements, including those of immunoglobulin and T-cell receptor genes, and the measurement of gene products, have been established. Techniques based on these approaches offer interesting tools for the detection of MRD. New possibilities of employing monoclonal anti bodies are also presented.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 9401083983
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 03 November 2011
Listed Since: 15 June 2013

Barcode

No barcode data available

Springer Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

Chemotherapy for Leukemia: Novel Drugs and Treatment

Springer - The Myelodysplastic Syndromes Medical Text

Acute Myelogenous Leukemia (Contemporary Hematology)

Acute Myeloid Leukemia (Hematologic Malignancies)

Humana Acute Myelogenous Leukemia - Contemporary Hematology

Advance in the Treatment of Pediatric Leukemia

Etiology of Acute Leukemias in Children

Acute Leukemias (Hematologic Malignancies)

Leukemias

The Genetic Basis of Haematological Cancers

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Consulting Hematology and Oncology Handbook

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)

MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)